OTCM
MSGP
Market cap31kUSD
Oct 08, Last price
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-99.88%
IPO
-99.94%
Name
Kenergy Scientific Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
Net income
-76k
L+34.30%
CFO
-43k
L-85.92%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MedSmart Group Inc. oversees a network of professional MedSmart wellness centers, primarily dedicated to providing anti-aging solutions. Their comprehensive suite of services includes hormone replacement therapies, such as testosterone replacement and general hormone restoration, cryogen therapy, and treatments for various health issues like hypothyroidism, allergies, high cholesterol, hypertension, and diabetes. Furthermore, the centers offer specialized programs like the Smart Diet and Medi-Fast, alongside aesthetic and health-related procedures, including vein treatment, laser hair removal, hair loss solutions, and erectile dysfunction treatment. The company's headquarters are situated in Bay Harbor Islands, Florida.
Key people
Zoran Cvetojevic
Chairman of the Board · since 2013
Adel Nasser
President, Chief Executive Officer, Director · since 2017
Manuel Canales
Chief Operating Officer · since 2017
Rajesh Babaria
Chief Technology Officer · since 2014
Rajesh Dholakiya
Chief Technology Officer · since 2014
Treasurer, Secretary · since 2013
Jelena Cvetojevic
Director · since 2013
Hugo Rubio
Director · since 2013
Andrea Zecevic
Director · since 2013
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||